Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA: 603707)

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Statistics

Total Valuation

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. has a market cap or net worth of CNY 22.94 billion. The enterprise value is 23.30 billion.

Market Cap	22.94B
Enterprise Value	23.30B

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	Jul 8, 2024

Share Statistics

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. has 1.62 billion shares outstanding. The number of shares has decreased by -1.71% in one year.

Current Share Class	n/a
Shares Outstanding	1.62B
Shares Change (YoY)	-1.71%
Shares Change (QoQ)	+2.60%
Owned by Insiders (%)	51.42%
Owned by Institutions (%)	11.03%
Float	441.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	26.54
PS Ratio	5.85
PB Ratio	3.66
P/TBV Ratio	3.84
P/FCF Ratio	26.89
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-55.08
EV / Sales	6.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	27.31

Financial Position

The company has a current ratio of 3.13, with a Debt / Equity ratio of 0.37.

Current Ratio	3.13
Quick Ratio	1.43
Debt / Equity	0.37
Debt / EBITDA	n/a
Debt / FCF	2.71
Interest Coverage	-6.56

Financial Efficiency

Return on equity (ROE) is -6.46% and return on invested capital (ROIC) is -3.36%.

Return on Equity (ROE)	-6.46%
Return on Assets (ROA)	-3.05%
Return on Capital (ROIC)	-3.36%
Revenue Per Employee	2.67M
Profits Per Employee	-291,501
Employee Count	1,451
Asset Turnover	0.38
Inventory Turnover	0.76

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.05% in the last 52 weeks. The beta is 0.52, so Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.'s price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	-8.05%
50-Day Moving Average	14.37
200-Day Moving Average	12.95
Relative Strength Index (RSI)	46.47
Average Volume (20 Days)	6,188,380

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. had revenue of CNY 3.88 billion and -422.97 million in losses. Loss per share was -0.26.

Revenue	3.88B
Gross Profit	385.77M
Operating Income	-501.54M
Pretax Income	-544.86M
Net Income	-422.97M
EBITDA	-341.18M
EBIT	-501.54M
Loss Per Share	-0.26

Balance Sheet

The company has 1.95 billion in cash and 2.31 billion in debt, giving a net cash position of -357.88 million or -0.22 per share.

Cash & Cash Equivalents	1.95B
Total Debt	2.31B
Net Cash	-357.88M
Net Cash Per Share	-0.22
Equity (Book Value)	6.27B
Book Value Per Share	3.88
Working Capital	4.73B

Cash Flow

In the last 12 months, operating cash flow was 1.50 billion and capital expenditures -649.94 million, giving a free cash flow of 853.11 million.

Operating Cash Flow	1.50B
Capital Expenditures	-649.94M
Free Cash Flow	853.11M
FCF Per Share	0.53

Margins

Gross margin is 9.95%, with operating and profit margins of -12.93% and -10.91%.

Gross Margin	9.95%
Operating Margin	-12.93%
Pretax Margin	-14.05%
Profit Margin	-10.91%
EBITDA Margin	-8.80%
EBIT Margin	-12.93%
FCF Margin	22.00%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.68%.

Dividend Per Share	0.10
Dividend Yield	0.68%
Dividend Growth (YoY)	-13.04%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.71%
Shareholder Yield	2.39%
Earnings Yield	-1.87%
FCF Yield	3.72%

Stock Splits

The last stock split was on July 11, 2022. It was a forward split with a ratio of 1.3.

Last Split Date	Jul 11, 2022
Split Type	Forward
Split Ratio	1.3

Scores

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. has an Altman Z-Score of 5.4.

Altman Z-Score	5.4
Piotroski F-Score	n/a